Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Significant Bleeding Risk”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Study completedNCT01675076
What this trial is testing

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

Who this might be right for
Hematoma
Ottawa Heart Institute Research Corporation 663
Not applicableUnknownNCT06335186
What this trial is testing

Predictive and Prognostic Significance of Age,Blood Tests,Comorbidities(ABC) Score,Cologne Watch(C-watch)Score and Rockall Score for Risk of Variceal Re-bleeding Among Cirrhotic Patients

Who this might be right for
Upper Gastrointestinal Variceal Bleeding in Cirrhotic Patients
Sohag University 100
Large-scale testing (Phase 3)Study completedNCT00375258
What this trial is testing

Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage

Who this might be right for
Hemorrhage
London School of Hygiene and Tropical Medicine 20,211
Not applicableLooking for participantsNCT07111221
What this trial is testing

Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss

Who this might be right for
Liver CirrhosisClinically Significant Portal Hypertension
Medical University of Warsaw 104
Not applicableLooking for participantsNCT06429787
What this trial is testing

Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

Who this might be right for
Vitamin K-Dependent Coagulation DefectSignificant Bleeding Risk
Octapharma 3,574
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208